Moroidin is a bicyclic plant octapeptide
with tryptophan side-chain
cross-links, originally isolated as a pain-causing agent from the
Australian stinging tree Dendrocnide moroides. Moroidin and its analog celogentin C, derived from Celosia argentea, are inhibitors of tubulin polymerization
and, thus, lead structures for cancer therapy. However, low isolation
yields from source plants and challenging organic synthesis hinder
moroidin-based drug development. Here, we present biosynthesis as
an alternative route to moroidin-type bicyclic peptides and report
that they are ribosomally synthesized and posttranslationally modified
peptides (RiPPs) derived from BURP-domain peptide cyclases in plants.
By mining 793 plant transcriptomes for moroidin core peptide motifs
within BURP-domain precursor peptides, we identified a moroidin cyclase
in Japanese kerria, which catalyzes the installation of the tryptophan-indole-centered
macrocyclic bonds of the moroidin bicyclic motif in the presence of
cupric ions. Based on the kerria moroidin cyclase, we demonstrate
the feasibility of producing diverse moroidins including celogentin
C in transgenic tobacco plants and report specific cytotoxicity of
celogentin C against a lung adenocarcinoma cancer cell line. Our study
sets the stage for future biosynthetic development of moroidin-based
therapeutics and highlights that mining plant transcriptomes can reveal
bioactive cyclic peptides and their underlying cyclases from new source
plants.